Viridian Therapeutics stockVRDN
Viridian Therapeutics trades at $28.55, 16.7% below its 52-week high (Jan 14, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. −8.3% year to date, +16.9% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 11, 2027.
Ratings, candles, signals and the screener for VRDN — after you log in
Open the terminalFrequently asked questions about Viridian Therapeutics
What is the Viridian Therapeutics stock price?
At the close on Nov 5, 2026: $28.55 (−1.74% on the day). 52-week high: $34.29 on Jan 14, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Viridian Therapeutics report earnings?
The next quarterly report is on Mar 11, 2027. Last quarter, earnings per share changed −138% year over year, revenue −64%.
Does Viridian Therapeutics pay dividends?
No, Viridian Therapeutics does not pay dividends.
Where does Viridian Therapeutics trade and how to buy it?
Ticker VRDN, exchange Nasdaq, listed since 2014. You can buy it through a broker with access to US exchanges.
Should I buy Viridian Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for VRDN are in the terminal after you log in.